Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04492072 · ClinicalTrials.gov registry record · NA
Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions
A NA study of Cesarean Section and High Risk Pregnancy, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT04492072: Completed NA study of Cesarean Section and High Risk Pregnancy, sponsored by Thomas Jefferson University.
NCT04492072 is a NA study of Cesarean Section and High Risk Pregnancy that has completed, run by Thomas Jefferson University. The registered enrollment target is 150 participants, roughly in line with the 160-participant average among 14 other Cesarean Section trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04492072, a NA study of Cesarean Section and High Risk Pregnancy, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to specifically investigate whether oxytocin and mechanical dilation decreases the rate of cesarean section compared to misoprostol and mechanical dilation for pregnancies at risk of fetal compromise
Primary Outcome
Total rate of cesarean delivery
Conditions Studied
Interventions
- DRUG Oxytocin
- DRUG Misoprostol
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2022-05-26 |
| Phase | NA |
What the finished NCT04492072 record still lists
NCT04492072 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 160-participant average among 14 other Cesarean Section trials with a reported enrollment target.
The record links to 4 conditions, with Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.
NCT04492072 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04492072 about?
NCT04492072 is a clinical study titled "Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions". The purpose of this study is to specifically investigate whether oxytocin and mechanical dilation decreases the rate of cesarean section compared to misoprostol and mechanical dilation for pregnancies at risk of fetal compromise
What is the current status of trial NCT04492072?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-08-17. Estimated completion is 2022-05-26.
What conditions does trial NCT04492072 study?
This clinical trial studies the following conditions: Cesarean Section, High Risk Pregnancy, Oxytocin, Misoprostol.
What interventions are being tested in trial NCT04492072?
The interventions under investigation include: Oxytocin (DRUG), Misoprostol (DRUG).
Who is sponsoring clinical trial NCT04492072?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04492072 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04492072's enrollment target sits among peer trials
150 5th of 14 higher than 9 of 14 other Cesarean Section trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Section trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
RECRUITING · NA
-
Post-operative Cesarean Trial of Pain Control
RECRUITING · NA
-
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
COMPLETED · NA
-
The Effects of Music Therapy on Women's Anxiety Before and During Cesarean Delivery
COMPLETED · NA
-
Chlorhexidine Gluconate Versus Povidone Iodine at Cesarean Delivery: a Randomized Controlled Trial
COMPLETED · NA
-
Using the Peanut Exercise Ball to Reduce Cesarean Section Rates: A Randomized Controlled Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI